Bleeding and Recurrence in Patients with Venous Thromboembolism with Changing Anticoagulant Treatment Patterns: Findings from the TROLL Registry
Blutungen und Rezidive bei Patient:innen mit venöser Thromboembolie und wechselnden Antikoagulanzien-Behandlungsmustern: Ergebnisse aus dem TROLL-Register
TH Open · 24.03.2026 · 10 (CP)
DOI: 10.1055/a-2832-8297 ↗Auf einen Blick
Bei 3.839 VTE-Patient:innen verschob sich die Behandlung von VKA zu DOAK. Major Bleeding nahm ab, CRNMB stieg, Rezidive nach Absetzen sanken.
Fragestellung
Wie verändern sich Major Bleeding, klinisch relevante nicht-major Blutungen und Rezidive bei wechselnden Antikoagulanzien-Behandlungsmustern bei VTE?
Methode
Kohortenstudie im Venous Thrombosis Registry in Østfold Hospital, Norwegen; VTE-Patient:innen 2005–2020 in 3 Zeitperioden; Vergleich der Blutungs- und Rezidivraten mittels Fine-Gray-Analyse.
Ergebnisse
3.839 Patient:innen. VKA: 76 % in Periode 1 auf 2 % in Periode 3; DOAK: 1 % auf 85 %. MB: 5,6 bis 3,1 pro 100 Personenjahre. CRNMB: 5,4 auf 7,7; sHR 1,87 (1,36–2,56). Rezidive: 5,1 auf 3,9; sHR 0,51 (0,41–0,65).
Schlussfolgerung der Autor:innen
VTE-Rezidive nach Absetzen der Antikoagulation sind zurückgegangen, vermutlich wegen längerfristiger Behandlung bei Hochrisikopatient:innen; CRNMB-Raten sind im Zeitverlauf gestiegen.
Kernaussagen
- VKA nahm von 76 % auf 2 % ab, DOAK stieg von 1 % auf 85 %
- CRNMB stieg auf 7,7 pro 100 Personenjahre; sHR 1,87
- Rezidive nach Absetzen sanken; sHR 0,51
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift TH Open, erschienen am 24.03.2026. Verfasst von Katarina Glise Sandblad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Treatment for venous thromboembolism (VTE) has shifted from vitamin K antagonists (VKAs) to direct oral anticoagulants (DOACs), with increased use of indefinite therapy. However, data on bleeding and recurrence outcomes associated with these changes remain limited.
Objective
To evaluate the risk of major bleeding (MB), clinically relevant nonmajor bleeding (CRNMB), and recurrence with changing treatment patterns.
Methods
Cancer-free VTE patients were identified in the Venous Thrombosis Registry in Østfold Hospital, Norway, from January 2005 to May 2020, and categorized into period 1 (2005–2012), period 2 (2013–2016), and period 3 (2017–2020). MB and CRNMB rates during anticoagulant treatment, and recurrence rates after anticoagulant discontinuation were assessed. Subhazard ratios (sHRs) were calculated using Fine-Gray analysis for time-period comparisons.
Results
Among 3,839 patients (48% female, median age: 67 years; IQR, 54–78), VKA use decreased from 76% in period 1 to 2% in period 3, while DOAC use increased from 1 to 85%. The MB rate ranged from 5.6 (95% confidence interval [CI]: 3.9–6.4) per 100 person-years in period 2 to 3.1 (2.3–4.2) in period 3. The CRNMB rate increased from 5.4 (95% CI: 4.3–6.9) per 100 person-years in period 1 to 7.7 (6.3–9.5) in period 3, sHR: 1.87 (1.36–2.56). Conversely, the recurrence rate decreased from 5.1 (95% CI: 4.6–5.6) per 100 person-years after anticoagulant discontinuation in period 1 to 3.9 (3.2–4.9) in period 3, sHR: 0.51 (0.41–0.65).
Conclusion
VTE recurrences after anticoagulant discontinuation have declined, likely due to indefinite treatment in patients at high risk of recurrence, while CRNMB rates have increased over time.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital/Östra, Region Västra Götaland, Gothenburg, Sweden.
- Department of Research, Østfold Hospital, Sarpsborg, Norway.
- Department of Acute Medicine and Geriatrics, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Institute of Clinical Medicine, University of Oslo, Østfold, Norway.
- Department of Emergency Medicine, Østfold Hospital, Sarpsborg, Norway.
ORCID-Profile: Katarina Glise Sandblad
Zitieren
APA
Glise Sandblad, K., Tavoly, M., Ghanima, W., & Jørgensen, C. T. (2026). Bleeding and Recurrence in Patients with Venous Thromboembolism with Changing Anticoagulant Treatment Patterns: Findings from the TROLL Registry. TH Open, 10(CP). https://doi.org/10.1055/a-2832-8297
Vancouver
Glise Sandblad K, Tavoly M, Ghanima W, Jørgensen CT. Bleeding and Recurrence in Patients with Venous Thromboembolism with Changing Anticoagulant Treatment Patterns: Findings from the TROLL Registry. TH Open. 2026;10(CP). doi:10.1055/a-2832-8297
BibTeX
@article{GliseSandblad2026,
author = {Glise Sandblad, Katarina and Tavoly, Mazdak and Ghanima, Waleed and Jørgensen, Camilla T},
title = {Bleeding and Recurrence in Patients with Venous Thromboembolism with Changing Anticoagulant Treatment Patterns: Findings from the TROLL Registry},
journal = {TH Open},
year = {2026},
volume = {10},
number = {CP},
doi = {10.1055/a-2832-8297}
}
EUVIMED